These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2160156

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Experiences with plasmapheresis in the treatment of vascular rejection following kidney transplantation].
    Eismann R, Konert J, Langkopf B.
    Z Urol Nephrol; 1990 Jan; 83(1):9-12. PubMed ID: 2330764
    [Abstract] [Full Text] [Related]

  • 24. [Multiple sclerosis--immunopathogenesis, traditional therapeutic strategy and suggested combined immunotherapy].
    Skotnicki AB, Aleksandrowicz J, Retinger-Grzesiuła M, Zduńczyk A, Grochmal S, Huczyński J.
    Postepy Hig Med Dosw; 1983 Jan; 37(1):1-32. PubMed ID: 6356094
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Immunosuppressive agents in multiple sclerosis. Preliminary trials with Proresid].
    Danielczyk W.
    Wien Med Wochenschr; 1968 Nov 02; 118(44):934-7. PubMed ID: 5710171
    [No Abstract] [Full Text] [Related]

  • 28. [Guidelines for drug treatment of multiple sclerosis].
    Kollegger H, Vass K, Marschall I, Koch G, Deecke L.
    Wien Klin Wochenschr; 1993 Nov 02; 105(16):443-52. PubMed ID: 7692677
    [Abstract] [Full Text] [Related]

  • 29. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F, Marteau R, de Saxcé H.
    Rev Neurol (Paris); 1987 Nov 02; 143(2):98-107. PubMed ID: 3299618
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunotherapeutics of multiple sclerosis.
    Durelli L.
    Acta Neurol (Napoli); 1991 Oct 02; 13(5):467-75. PubMed ID: 1723242
    [Abstract] [Full Text] [Related]

  • 32. [50th contribution of the Central Expert Committee for Drug Trade, Section Human Medicine].
    Poppe W, Schwenkbier H, Wieczorek V.
    Dtsch Gesundheitsw; 1973 Jan 03; 28(3):136-9. PubMed ID: 4348072
    [No Abstract] [Full Text] [Related]

  • 33. [Immunosuppressive therapy].
    Schumacher K, Gross R.
    Internist (Berl); 1984 Jan 03; 25(1):51-9. PubMed ID: 6370894
    [No Abstract] [Full Text] [Related]

  • 34. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
    Weiner HL.
    Arch Neurol; 2004 Oct 03; 61(10):1613-5. PubMed ID: 15477521
    [No Abstract] [Full Text] [Related]

  • 35. [Multiple sclerosis: from immunopathogenesis to disease management].
    Nervenarzt; 1996 Dec 03; 67(12 Suppl Von Der Im):1-8. PubMed ID: 9403091
    [No Abstract] [Full Text] [Related]

  • 36. Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome.
    Pachioli R, Genova R.
    Pediatrics; 1971 Apr 03; 47(4):731-6. PubMed ID: 4326172
    [No Abstract] [Full Text] [Related]

  • 37. Lupus nephritis: classification, clinical features, and treatment.
    Weissleder R, Galarza DA, Garza MA.
    Rev Invest Clin; 1987 Apr 03; 39(3):263-76. PubMed ID: 3324251
    [No Abstract] [Full Text] [Related]

  • 38. [Experiences with immunosuppressive treatment of multiple sclerosis].
    Wieczorek V, Lehnert W, Brodkorb W.
    Dtsch Gesundheitsw; 1971 Sep 16; 26(38):1791-4. PubMed ID: 5142348
    [No Abstract] [Full Text] [Related]

  • 39. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N, Quartuccio L, De Marchi G, De Vita S.
    Reumatismo; 2007 Sep 16; 59(3):202-8. PubMed ID: 17898879
    [Abstract] [Full Text] [Related]

  • 40. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep 16; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.